These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 28604170

  • 1. Efficacy of Mycobacterium vaccae immunotherapy for patients with tuberculosis: A systematic review and meta-analysis.
    Huang CY, Hsieh WY.
    Hum Vaccin Immunother; 2017 Sep 02; 13(9):1960-1971. PubMed ID: 28604170
    [Abstract] [Full Text] [Related]

  • 2. Mycobacterium vaccae as adjuvant therapy to anti-tuberculosis chemotherapy in never-treated tuberculosis patients: a meta-analysis.
    Yang XY, Chen QF, Li YP, Wu SM.
    PLoS One; 2011 Sep 02; 6(9):e23826. PubMed ID: 21909406
    [Abstract] [Full Text] [Related]

  • 3. Immunotherapy with Mycobacterium vaccae as an addition to chemotherapy for the treatment of pulmonary tuberculosis under difficult conditions in Africa.
    Onyebujoh PC, Abdulmumini T, Robinson S, Rook GA, Stanford JL.
    Respir Med; 1995 Mar 02; 89(3):199-207. PubMed ID: 7746913
    [Abstract] [Full Text] [Related]

  • 4. Randomized, placebo-controlled phase II trial of heat-killed Mycobacterium vaccae (Longcom batch) formulated as an oral pill (V7).
    Efremenko YV, Butov DA, Prihoda ND, Zaitzeva SI, Yurchenko LV, Sokolenko NI, Butova TS, Stepanenko AL, Kutsyna GA, Jirathitikal V, Bourinbaiar AS.
    Hum Vaccin Immunother; 2013 Sep 02; 9(9):1852-6. PubMed ID: 23782489
    [Abstract] [Full Text] [Related]

  • 5. Immunotherapy with Mycobacterium vaccae in patients with newly diagnosed pulmonary tuberculosis: a randomised controlled trial. Durban Immunotherapy Trial Group.
    Lancet; 1999 Jul 10; 354(9173):116-9. PubMed ID: 10408487
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Mycobacterium vaccae immunotherapy for treating tuberculosis.
    de Bruyn G, Garner P.
    Cochrane Database Syst Rev; 2003 Jul 10; (1):CD001166. PubMed ID: 12535403
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [A clinical study on vaccine of Mycobacterium vaccae in treating pulmonary tuberculosis].
    Wang W, Jin G, Ye Y, Xia X, Wang A, Zhuang Y, Li G, Sun H, Wang Z, Lin M, Chen H, Li J, Dan Z, Zhang X.
    Zhonghua Jie He He Hu Xi Za Zhi; 1999 Feb 10; 22(2):108-10. PubMed ID: 11820954
    [Abstract] [Full Text] [Related]

  • 11. Double-blind placebo-controlled trial of Mycobacterium vaccae immunotherapy for tuberculosis in KwaZulu, South Africa, 1991-97.
    Mayo RE, Stanford JL.
    Trans R Soc Trop Med Hyg; 2000 Feb 10; 94(5):563-8. PubMed ID: 11132390
    [Abstract] [Full Text] [Related]

  • 12. Immunological consequences of three doses of heat-killed Mycobacterium vaccae in the immunotherapy of tuberculosis.
    Dlugovitzky D, Fiorenza G, Farroni M, Bogue C, Stanford C, Stanford J.
    Respir Med; 2006 Jun 10; 100(6):1079-87. PubMed ID: 16278080
    [Abstract] [Full Text] [Related]

  • 13. Effect of Mycobacterium vaccae (SRL172) immunotherapy on radiographic healing in tuberculosis.
    Johnson JL, Nunn AJ, Fourie PB, Ormerod LP, Mugerwa RD, Mwinga A, Chintu C, Ngwira B, Onyebujoh P, Zumla A.
    Int J Tuberc Lung Dis; 2004 Nov 10; 8(11):1348-54. PubMed ID: 15581204
    [Abstract] [Full Text] [Related]

  • 14. Randomized controlled trial of Mycobacterium vaccae immunotherapy in non-human immunodeficiency virus-infected ugandan adults with newly diagnosed pulmonary tuberculosis. The Uganda-Case Western Reserve University Research Collaboration.
    Johnson JL, Kamya RM, Okwera A, Loughlin AM, Nyole S, Hom DL, Wallis RS, Hirsch CS, Wolski K, Foulds J, Mugerwa RD, Ellner JJ.
    J Infect Dis; 2000 Apr 10; 181(4):1304-12. PubMed ID: 10753731
    [Abstract] [Full Text] [Related]

  • 15. Orally administered Mycobacterium vaccae modulates expression of immunoregulatory molecules in BALB/c mice with pulmonary tuberculosis.
    Hernández-Pando R, Aguilar D, Orozco H, Cortez Y, Brunet LR, Rook GA.
    Clin Vaccine Immunol; 2008 Nov 10; 15(11):1730-6. PubMed ID: 18827195
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Mycobacterium vaccae immunotherapy for treating tuberculosis.
    de Bruyn G, Garner P.
    Cochrane Database Syst Rev; 2000 Nov 10; 2003(2):CD001166. PubMed ID: 10796609
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Does immunotherapy with heat-killed Mycobacterium vaccae offer hope for the treatment of multi-drug-resistant pulmonary tuberculosis?
    Stanford JL, Stanford CA, Grange JM, Lan NN, Etemadi A.
    Respir Med; 2001 Jun 10; 95(6):444-7. PubMed ID: 11421500
    [Abstract] [Full Text] [Related]

  • 20. Therapeutic effects of recombinant human interleukin 2 as adjunctive immunotherapy against tuberculosis: A systematic review and meta-analysis.
    Zhang R, Xi X, Wang C, Pan Y, Ge C, Zhang L, Zhang S, Liu H.
    PLoS One; 2018 Jun 10; 13(7):e0201025. PubMed ID: 30024982
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.